Medications
Parents scrambling after asthma inhaler Flovent removed from market
A popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids.
Feb 21, 2024
0
0
News tagged with gsk
Other
GSK buys asthma drug developer for up to $1.4 bn
British drugmaker GlaxoSmithKline on Tuesday agreed to buy Aiolos Bio for up to $1.4 billion, with focus on an asthma medication still at the testing stage.
Jan 9, 2024
0
1
Vaccination
GSK sues Pfizer over patents for RSV vaccine
GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.
Aug 2, 2023
0
0
Other
Drugmaker settles US Zantac cancer case
British pharmaceutical group GlaxoSmithKline said Friday it has settled a US lawsuit which had alleged heartburn drug Zantac caused cancer, but admitted no liability.
Jun 23, 2023
0
35
Gerontology & Geriatrics
CDC panel backs RSV shots for seniors
An advisory panel of the U.S.Centers for Disease Control and Prevention voted on Wednesday to recommend the first RSV vaccines for seniors.
Jun 22, 2023
0
7
Diseases, Conditions, Syndromes
EU approves first vaccine against common respiratory virus
The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.
Jun 7, 2023
0
2
Diseases, Conditions, Syndromes
First RSV vaccine caps 60-year search to stem pervasive lung illness
For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
May 6, 2023
0
26
Vaccination
EU watchdog backs GSK's RSV vaccine for over 60s
The European Union's drug watchdog has recommended approval of pharmaceutical giant GSK's vaccine against the RSV respiratory virus for over-60s, the British firm said on Thursday.
Apr 27, 2023
0
1
Oncology & Cancer
Drugmaker GSK says EU to review womb cancer treatment
British pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in the European market.
Apr 25, 2023
0
2
Other
Glaxo buys Canadian cough drug maker for $2 bn
British drugmaker GlaxoSmithKline on Tuesday announced the purchase of Canadian chronic cough treatment specialist Bellus for US$2 billion.
Apr 18, 2023
0
2
